Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|July 2, 2021
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?Miriam Sciaccaluga, Alfredo Megaro, Giovanni Bellomo, et al.
Chemical Communications (Cambridge, England)|May 17, 2018
Aggregation kinetics of the Aβ1-40 peptide monitored by NMRGiovanni Bellomo, Sara Bologna, Leonardo Gonnelli, et al.
Magnetic Resonance (Gottingen, Germany)|October 31, 2023
Revisiting paramagnetic relaxation enhancements in slowly rotating systems: how long is the long range?Giovanni Bellomo, Enrico Ravera, Vito Calderone, et al.
Frontiers in Bioscience (Landmark Edition)|December 3, 2021
Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factorsGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Neurobiology of Disease|December 24, 2025
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's diseaseGiovanni Bellomo, Andrea Toja, Lorenzo Gaetani, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy BodiesGiovanni Bellomo, Federico Paolini Paoletti, Elena Chipi, et al.
Clinical Chemistry and Laboratory Medicine|May 6, 2021
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementSilvia Paciotti, Erik Stoops, Cindy François, et al.
Plos One|November 11, 2016
MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite QuantificationGiovanni Bellomo, Francesco Marcocci, David Bianchini, et al.
Trends in Pharmacological Sciences|October 31, 2020
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for TreatmentLorenzo Gaetani, Federico Paolini Paoletti, Giovanni Bellomo, et al.
Journal of Alzheimer'S Disease : JAD|July 5, 2022
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical ValidationAnna Lidia Wojdała, Davide Chiasserini, Giovanni Bellomo, et al.
Pageof 6